Peter Carlsen
6Patents
0h-index
31Co-inventors
37Inventor score
Filing activity: Apr 8, 2019 → Feb 9, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US12060433B2 | CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy | Chemistry; Metallurgy | 0 | Active |
| US11999740B2 | Fused pyrazine derivatives as A2A / A2B inhibitors | Chemistry; Metallurgy | 0 | Active |
| US11999752B2 | Vinyl imidazole compounds as inhibitors of KRAS | Chemistry; Metallurgy | 0 | Active |
| US12030883B2 | Hetero-tricyclic compounds as inhibitors of KRAS | Chemistry; Metallurgy | 0 | Active |
| US11220510B2 | Pyrrole tricyclic compounds as A2A / A2B inhibitors | Chemistry; Metallurgy | 0 | Active |
| US12378243B2 | Quinoline compounds as inhibitors of KRAS | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.